Onderneming Merrimack Pharmaceuticals Inc Nasdaq
Aandelen
US5903281005
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 01-01-93 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 01-01-04 |
Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 01-01-04 |
Director/Board Member | 45 | 19-09-19 | |
Ulrik Nielsen
FOU | Founder | 52 | 01-01-93 |
Director/Board Member | 46 | 19-09-19 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 06-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 531 760 | 14 355 601 ( 98,79 %) | 0 | 98,79 % |
Bedrijfsgegevens
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 48,16 mld. | |
-0,10% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+11,48% | 25,59 mld. | |
-22,74% | 18,96 mld. | |
+9,06% | 12,92 mld. | |
+30,01% | 12,03 mld. | |
-1,51% | 11,77 mld. |